• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种环四肽(“环多拉肽”)及其镜像异构体均为高亲和力μ阿片受体拮抗剂。

A Cyclic Tetrapeptide ("Cyclodal") and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists.

作者信息

Weltrowska Grazyna, Nguyen Thi M-D, Chung Nga N, Wood JodiAnne, Ma Xiaoyu, Guo Jason, Wilkes Brian C, Ge Yang, Laferrière André, Coderre Terence J, Schiller Peter W

机构信息

Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal , 110 Pine Avenue des Pins Ouest, Montreal, Quebec H2W 1R7, Canada.

Center for Drug Discovery, Northeastern University , 360 Huntington Avenue, Boston, Massachusetts 02115, United States.

出版信息

J Med Chem. 2016 Oct 13;59(19):9243-9254. doi: 10.1021/acs.jmedchem.6b01200. Epub 2016 Oct 3.

DOI:10.1021/acs.jmedchem.6b01200
PMID:27676089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5222732/
Abstract

Head-to-tail cyclization of the μ opioid receptor (MOR) agonist [Dmt]DALDA (H-Dmt-d-Arg-Phe-Lys-NH (9; Dmt = 2',6'-dimethyltyrosine) resulted in a highly active, selective MOR antagonist, c[-d-Arg-Phe-Lys-Dmt-] (1) ("cyclodal"), with subnanomolar binding affinity. A docking study of cyclodal using the crystal structure of MOR in the inactive form showed a unique binding mode with the two basic residues of the ligand forming salt bridges with the Asp and Glu receptor residues. Cyclodal showed high plasma stability and was able to cross the blood-brain barrier to reverse morphine-induced, centrally mediated analgesia when given intravenously. Surprisingly, the mirror-image isomer (optical antipode) of cyclodal, c[-Arg-d-Phe-d-Lys-d-Dmt-] (2), also turned out to be a selective MOR antagonist with 1 nM binding affinity, and thus, these two compounds represent the first example of mirror image opioid receptor ligands with both optical antipodes having high binding affinity. Reduction of the Lys-Dmt peptide bond in cyclodal resulted in an analogue, c[-d-Arg-Phe-LysΨ[CHNH]Dmt-] (8), with MOR agonist activity.

摘要

μ阿片受体(MOR)激动剂[Dmt]DALDA(H-Dmt-d-Arg-Phe-Lys-NH(9;Dmt = 2',6'-二甲基酪氨酸)的首尾环化产生了一种高活性、选择性的MOR拮抗剂c[-d-Arg-Phe-Lys-Dmt-](1)(“环达”),其结合亲和力为亚纳摩尔。使用非活性形式的MOR晶体结构对环达进行的对接研究显示了一种独特的结合模式,配体的两个碱性残基与受体的Asp和Glu残基形成盐桥。环达表现出高血浆稳定性,静脉注射时能够穿过血脑屏障,逆转吗啡诱导的中枢介导的镇痛作用。令人惊讶的是,环达的镜像异构体(旋光对映体)c[-Arg-d-Phe-d-Lys-d-Dmt-](2)也被证明是一种具有1 nM结合亲和力的选择性MOR拮抗剂,因此,这两种化合物代表了镜像阿片受体配体的首个例子,其两个旋光对映体都具有高结合亲和力。环达中Lys-Dmt肽键的还原产生了一种具有MOR激动剂活性的类似物c[-d-Arg-Phe-LysΨ[CHNH]Dmt-](8)。

相似文献

1
A Cyclic Tetrapeptide ("Cyclodal") and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists.一种环四肽(“环多拉肽”)及其镜像异构体均为高亲和力μ阿片受体拮抗剂。
J Med Chem. 2016 Oct 13;59(19):9243-9254. doi: 10.1021/acs.jmedchem.6b01200. Epub 2016 Oct 3.
2
Equipotent enantiomers of cyclic opioid peptides at μ opioid receptor.环阿片肽在μ阿片受体上的等效对映体。
Pept Sci (Hoboken). 2019 Jan;111(1). doi: 10.1002/pep2.24078. Epub 2018 May 25.
3
Characterization of the binding of [3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2, a highly potent opioid peptide.强效阿片肽[3H][Dmt1]H-Dmt-D-Arg-Phe-Lys-NH2的结合特性研究
J Pharmacol Exp Ther. 2003 Aug;306(2):430-6. doi: 10.1124/jpet.103.049742. Epub 2003 Mar 27.
4
Novel µ opioid antagonists derived from the µ opioid agonists endomorphin and [Dmt ]DALDA (H-Dmt-D-Arg-Phe-Lys-NH ).新型 μ 阿片受体拮抗剂来源于 μ 阿片受体激动剂内吗啡肽和 [Dmt]DALDA(H-Dmt-D-Arg-Phe-Lys-NH2)。
Chem Biol Drug Des. 2020 Nov;96(5):1305-1314. doi: 10.1111/cbdd.13743. Epub 2020 Aug 2.
5
Characterization of the antinociceptive effects of intrathecal DALDA peptides following bolus intrathecal delivery.鞘内推注给药后鞘内注射DALDA肽的抗伤害感受作用的表征。
Scand J Pain. 2019 Jan 28;19(1):193-206. doi: 10.1515/sjpain-2018-0120.
6
In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH, a mu opioid receptor agonist biased toward β-arrestin.环肽 Dmt-c[d-Lys-Phe-Asp]NH 对μ阿片受体具有激动作用,偏向β-arrestin,体内外活性研究。
Peptides. 2018 Jul;105:51-57. doi: 10.1016/j.peptides.2018.04.014. Epub 2018 Apr 22.
7
Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration.合成具有系统给药后抗伤害感受活性的混合 MOR/KOR 效力环阿片肽类似物。
Eur J Med Chem. 2016 Feb 15;109:276-86. doi: 10.1016/j.ejmech.2015.12.012. Epub 2015 Dec 12.
8
Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA.内源性阿片肽有助于鞘内注射[Dmt1]DALDA的抗伤害感受效能。
J Pharmacol Exp Ther. 2003 May;305(2):696-702. doi: 10.1124/jpet.102.048561. Epub 2003 Jan 24.
9
Type and location of fluorescent probes incorporated into the potent mu-opioid peptide [Dmt]DALDA affect potency, receptor selectivity and intrinsic efficacy.掺入强效μ-阿片肽[Dmt]DALDA的荧光探针的类型和位置会影响效力、受体选择性和内在活性。
J Pept Res. 2005 Jun;65(6):556-63. doi: 10.1111/j.1399-3011.2005.00252.x.
10
Opioid peptide-derived analgesics.阿片肽衍生的镇痛药。
AAPS J. 2005 Oct 14;7(3):E560-5. doi: 10.1208/aapsj070356.

引用本文的文献

1
Production of constrained L-cyclo-tetrapeptides by epimerization-resistant direct aminolysis.通过非对映选择性直接氨解反应生产约束型 L-环四肽。
Nat Commun. 2024 Jun 25;15(1):5372. doi: 10.1038/s41467-024-49329-3.
2
Macrocyclic Tetramers-Structural Investigation of Peptide-Peptoid Hybrids.大环四聚体 - 肽 - 缩醛混合结构研究。
Molecules. 2021 Jul 28;26(15):4548. doi: 10.3390/molecules26154548.
3
Equipotent enantiomers of cyclic opioid peptides at μ opioid receptor.环阿片肽在μ阿片受体上的等效对映体。

本文引用的文献

1
The bifunctional μ opioid agonist/antioxidant [Dmt(1)]DALDA is a superior analgesic in an animal model of complex regional pain syndrome-type i.双功能μ阿片受体激动剂/抗氧化剂[Dmt(1)]DALDA在I型复杂性区域疼痛综合征动物模型中是一种更有效的镇痛药。
ACS Chem Neurosci. 2015 Nov 18;6(11):1789-93. doi: 10.1021/acschemneuro.5b00228. Epub 2015 Sep 14.
2
Structural insights into µ-opioid receptor activation.μ-阿片受体激活的结构见解
Nature. 2015 Aug 20;524(7565):315-21. doi: 10.1038/nature14886. Epub 2015 Aug 5.
3
Structural basis for bifunctional peptide recognition at human δ-opioid receptor.
Pept Sci (Hoboken). 2019 Jan;111(1). doi: 10.1002/pep2.24078. Epub 2018 May 25.
4
Antinociceptive potency of a fluorinated cyclopeptide Dmt-c[D-Lys-Phe-p-CF-Phe-Asp]NH.一种氟化环肽Dmt-c[D-赖氨酸-苯丙氨酸-对氟苯丙氨酸-天冬氨酸]NH的抗伤害感受效能
J Enzyme Inhib Med Chem. 2018 Dec;33(1):560-566. doi: 10.1080/14756366.2018.1441839.
5
χ-Space Screening of Dermorphin-Based Tetrapeptides through Use of Constrained Arylazepinone and Quinolinone Scaffolds.通过使用受限芳基氮杂环庚烷酮和喹啉酮支架对基于 Dermorphin 的四肽进行 χ 空间筛选。
ACS Med Chem Lett. 2017 Oct 4;8(11):1177-1182. doi: 10.1021/acsmedchemlett.7b00347. eCollection 2017 Nov 9.
人δ-阿片受体双功能肽识别的结构基础。
Nat Struct Mol Biol. 2015 Mar;22(3):265-8. doi: 10.1038/nsmb.2965. Epub 2015 Feb 16.
4
[Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profile.[Dmt(1)]具有增强的μ阿片受体激动剂效力和混合的μ/κ阿片活性特征的DALDA类似物。
Bioorg Med Chem. 2014 Apr 1;22(7):2333-8. doi: 10.1016/j.bmc.2014.02.011. Epub 2014 Feb 19.
5
Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour.[D-色氨酸]CJ-15,208的丙氨酸类似物:新型阿片样物质活性谱以及对药物和应激诱导的可卡因觅药行为复燃的预防作用
Br J Pharmacol. 2014 Jul;171(13):3212-22. doi: 10.1111/bph.12664.
6
Molecular control of δ-opioid receptor signalling.δ-阿片受体信号转导的分子调控。
Nature. 2014 Feb 13;506(7487):191-6. doi: 10.1038/nature12944. Epub 2014 Jan 12.
7
Preliminary pharmacological evaluation of enantiomeric morphinans.手性吗啡烷类的初步药理学评价。
ACS Chem Neurosci. 2014 Feb 19;5(2):93-9. doi: 10.1021/cn400205z. Epub 2014 Jan 8.
8
Vicinal disulfide constrained cyclic peptidomimetics: a turn mimetic scaffold targeting the norepinephrine transporter.邻二硫键约束的环肽模拟物:一种靶向去甲肾上腺素转运体的转角模拟支架
Angew Chem Int Ed Engl. 2013 Nov 11;52(46):12020-3. doi: 10.1002/anie.201304660. Epub 2013 Sep 24.
9
Superior analgesic effect of H-Dmt-D-Arg-Phe-Lys-NH2 ([Dmt1]DALDA), a multifunctional opioid peptide, compared to morphine in a rat model of neuropathic pain.在神经病理性疼痛的大鼠模型中,多功能阿片肽 H-Dmt-D-Arg-Phe-Lys-NH2([Dmt1]DALDA)的镇痛效果优于吗啡。
Chem Biol Drug Des. 2012 Nov;80(5):771-4. doi: 10.1111/cbdd.12003. Epub 2012 Sep 3.
10
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.μ-阿片受体与吗啡喃拮抗剂结合的晶体结构
Nature. 2012 Mar 21;485(7398):321-6. doi: 10.1038/nature10954.